ema tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide And Semaglutide: Experts Explain

How Long Until You See Results from Retatrutide

Retatrutide is the most powerful weight loss peptide in clinical development right now, a triple agonist that hits GLP-1, GIP, and glucagon receptors simultaneously

If you care about personalization, EllieMD wins by a mile

Tirzepatide once weekly for the treatment of obesity, The New England Journal of Medicine (2022) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity, JAMA Internal Medicine (2024) CVS Health announces it will drop Zepbound and prioritize coverage of Wegovy, Pharmacy Times (2025) Ozempic, DailyMed (2025) Zepbound, DailyMed (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice